Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP314878.RAI9DWwdD8hj_3OjY-JhFugveoDsVG8gI5wWC5libG6SQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP314878.RAI9DWwdD8hj_3OjY-JhFugveoDsVG8gI5wWC5libG6SQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP314878.RAI9DWwdD8hj_3OjY-JhFugveoDsVG8gI5wWC5libG6SQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP314878.RAI9DWwdD8hj_3OjY-JhFugveoDsVG8gI5wWC5libG6SQ130_provenance.
- NP314878.RAI9DWwdD8hj_3OjY-JhFugveoDsVG8gI5wWC5libG6SQ130_assertion description "[Trastuzumab is considered effective against human epidermal growth factor receptor (HER)-2-positive breast cancer as assessed by immunohistochemistry (IHC) and fluorescence or chromogenic in situ hybridization (FISH/CISH) on biopsy material.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP314878.RAI9DWwdD8hj_3OjY-JhFugveoDsVG8gI5wWC5libG6SQ130_provenance.
- NP314878.RAI9DWwdD8hj_3OjY-JhFugveoDsVG8gI5wWC5libG6SQ130_assertion evidence source_evidence_literature NP314878.RAI9DWwdD8hj_3OjY-JhFugveoDsVG8gI5wWC5libG6SQ130_provenance.
- NP314878.RAI9DWwdD8hj_3OjY-JhFugveoDsVG8gI5wWC5libG6SQ130_assertion SIO_000772 18448549 NP314878.RAI9DWwdD8hj_3OjY-JhFugveoDsVG8gI5wWC5libG6SQ130_provenance.
- NP314878.RAI9DWwdD8hj_3OjY-JhFugveoDsVG8gI5wWC5libG6SQ130_assertion wasDerivedFrom befree-20150227 NP314878.RAI9DWwdD8hj_3OjY-JhFugveoDsVG8gI5wWC5libG6SQ130_provenance.
- NP314878.RAI9DWwdD8hj_3OjY-JhFugveoDsVG8gI5wWC5libG6SQ130_assertion wasGeneratedBy ECO_0000203 NP314878.RAI9DWwdD8hj_3OjY-JhFugveoDsVG8gI5wWC5libG6SQ130_provenance.
- befree-20150227 importedOn "2015-02-27" NP314878.RAI9DWwdD8hj_3OjY-JhFugveoDsVG8gI5wWC5libG6SQ130_provenance.